A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia

Blood

Volumn 114, Issue 9, 2009, Pages 1746-1752

  Kadan Lottick, Nina S ^a   Brouwers, Pim ^b,c   Breiger, David ^d   Kaleita, Thomas ^e   Dziura, James ^f   Liu, Haibei ^f   Chen, Lu ^g   Nicoletti, Megan ^a   Stork, Linda ^h   Bostrom, Bruce ⁱ   Neglia, Joseph P ^j  

^a YALE CANCER CENTER   (United States)

^b TEXAS CHILDREN S CANCER CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CHILDREN S ONCOLOGY GROUP   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^j UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PREDNISONE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ACADEMIC ACHIEVEMENT; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SPECIAL EDUCATION; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; INFANT; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, HORMONAL; CHILD; CHILD, PRESCHOOL; COGNITION; CROSS-SECTIONAL STUDIES; DEXAMETHASONE; FEMALE; HUMANS; INFANT; MALE; NEUROPSYCHOLOGICAL TESTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 70349247009     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-186502     Document Type: Article

References (36)

1. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003;101(10):3809-3817.
2. Jones B, Freeman AI, Shuster JJ, et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol. 1991;19(4):269-275.
3. Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol. 2005;129(6):734-745. (Pubitemid 40904523)
4. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt- Munster. Leukemia. 2000;14(12):2205-2222.
5. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987;5(2):202-207.
6. Matloub Y, Angiolillo A, Bostrom B, et al. Double delayed intensification (DDI) is equivalent to single DI (SDI) in children with National Cancer Institute (NCI) standard-risk acute lymphoblastic leukemia (SR-ALL) treated on Children's Cancer Group (CCG) Clinical Trial 1991 (CCG-1991) [abstract]. ASH Annual Meeting Abstracts. 2006;108(11):146.
7. Buizer AI, de Sonneville LM, van den Heuvel- Eibrink MM, Veerman AJ. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer. 2005;45(3):281-290.
8. Mennes M, Stiers P, Vandenbussche E, et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer. 2005;44(5):478-486.
9. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of cns chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000;15(7):603-630. (Pubitemid 30750703)
10. Ochs J, Mulhern R, Fairclough D, et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol. 1991;9(1):145-151.
11. Peterson CC, Johnson CE, Ramirez LY, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51(1):99-104.
12. von der Weid N, Mosimann I, Hirt A, et al. Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences. Eur J Cancer. 2003;39(3):359-365. (Pubitemid 36140054)
13. Bender BG, Lerner JA, Poland JE. Association between corticosteroids and psychologic change in hospitalized asthmatic children. Ann Allergy. 1991;66(5):414-419.
14. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004; 350(13):1304-1313. (Pubitemid 38375365)
15. Young AH, Sahakian BJ, Robbins TW, Cowen PJ. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl). 1999;145(3): 260-266.
16. Danilczuk Z, Ossowska G, Lupina T, Cieslik K, Zebrowska-Lupina I. Effect of NMDA receptor antagonists on behavioral impairment induced by chronic treatment with dexamethasone. Pharmacol Rep. 2005;57(1):47-54. (Pubitemid 40601540)
17. Waber DP, Tarbell NJ, Fairclough D, et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol. 1995;13(10):2490-2496.
18. Paniucki H, Krull K, Mahoney D, Mueller B, Brouwers P. Effect of cerbrovascular complications and gender on children with sickle cell disease [abstract]. J Int Neuropsychol Soc. 2002; 8(2):241.
19. Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol. 1998;16(5): 1723-1728. (Pubitemid 28234715)
20. Jankovic M, Brouwers P, Valsecchi MG, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia: ISPACC: International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet. 1994;344(8917):224-227.
21. Taylor HG, Alden J. Age-related differences in outcomes following childhood brain insults: an introduction and overview. J Int Neuropsychol Soc. 1997;3(6):555-567. (Pubitemid 27510839)
22. Hack M, Breslau N, Aram D, Weissman B, Klein N, Borawski-Clark E. The effect of very low birth weight and social risk on neurocognitive abilities at school age. J Dev Behav Pediatr. 1992;13(6): 412-420.
23. Kaleita TA. Central nervous system-directed therapy in the treatment of childhood acute lymphoblastic leukemia and studies of neurobehavioral outcome: Children's Cancer Group trials. Curr Oncol Rep. 2002;4(2):131-141.
24. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996;14(1):18-24. (Pubitemid 26019992)
25. Kaleita TA, Noll RB, Stehbens JA, et al. Age at diagnosis of acute lymphoblastic leukemia is associated with neurobehavioral outcomes independent of CNS-directed treatment with or without cranial irradiation and intensive chemotherapy: a Children's Cancer Group report [abstract]. Ped Res. 2002;51:236A.
26. Waber DP, Carpentieri SC, Klar N, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol. 2000;22(3):206-213. (Pubitemid 32268304)
27. Copeland DR, Fletcher JM, Pfefferbaum-Levine B, Jaffe N, Ried H, Maor M. Neuropsychological sequelae of childhood cancer in long-term survivors. Pediatrics. 1985;75(4):745-753. (Pubitemid 15079531)
28. Kingma A, Van Dommelen R, Mooyaart E, Wilmink J, Deelman B, Kamps W. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study. J Ped Hematol Oncol. 2002;24(2):106-114. (Pubitemid 34150549)
29. Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late-effects after ALL therapy in childhood, part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol. 2002;38(5): 320-328. (Pubitemid 34493111)
30. Jansen NC, Kingma A, Schuitema A, Bouma A, Veerman AJ, Kamps WA. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia. J Clin Oncol. 2008;26(18):3025-3030.
31. Jansen NC, Kingma A, Schuitema A, et al. Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, siblingcontrolled study. Eur J Cancer. 2006;42(16): 2765-2772. (Pubitemid 44584660)
32. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol. 1998;23(5):333-340. (Pubitemid 28432425)
33. Brouwers P. Study of the neurobehavioral consequences of childhood cancer: entering the genomic era? J Ped Psychol. 2005;30(1):79-84. (Pubitemid 40041443)
34. Pui C-H, Relling M, Sandlund J, Downing J, Campana D, Evans W. Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol. 2004;83(suppl 1):S124-S126.
35. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11): 2292-2299. (Pubitemid 38657875)
36. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19(4):623-629.